LOADING
Comparing AbbVie Inc (ABBV) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $414.8B | $295.4B |
| P/E Ratio | 115.1 | 33.7 |
| Forward P/E | 16.5 | 23.6 |
| PEG Ratio | 0.65 | 5.56 |
| EPS | $2.04 | $3.55 |
| Revenue Growth (YoY) | 12.4% | 4.9% |
| Profit Margin | 5.8% | 13.6% |
| Return on Equity | 62.3% | 18.9% |
| Dividend Yield | 2.93% | 2.84% |
| Beta | 0.31 | 0.22 |
| 52-Week High | $239.13 | $123.33 |
| 52-Week Low | $176.00 | $74.18 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.